<DOC>
	<DOCNO>NCT02277990</DOCNO>
	<brief_summary>Medtronic , Inc. sponsor World-wide Randomized Antibiotic Envelope Infection Prevention Trial ( WRAP-IT ) , randomize , prospective , multi-center , single blind , post-market , interventional clinical study . This study evaluate ability TYRX envelope reduce major CIED infection 12-months post-procedure follow CIED generator replacement , upgrade , revision , de novo CRT-D implant . Additionally , large device study provide unique opportunity prospectively characterize performance Medtronic 's lead monitoring feature subject whose CIED system include transvenous RV defibrillation lead . Finally , WRAP-IT study serve post-approval study geography require post-approval study TYRX envelope .</brief_summary>
	<brief_title>World-wide Randomized Antibiotic Envelope Infection Prevention Trial</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Patient willing sign date study PIC form Patient least 18 year age meet age requirement per local law Patient plan undergo least one following : . Patient exist CIED undergo IPG ( include CRTP ) , ICD CRTD replacement upgrade new Medtronic generator . Subjects plan lead add , extract add upgrade enrol OR b . Patient undergo de novo Medtronic CRTD system implant per approve indication OR c. Patient exist study eligible Medtronic CIED pocket access within last 365 day , undergo pocket lead revision Willing provide contact information physician provide followup his/her CIED Willing able comply schedule followup study related activity Known allergy minocycline rifampin derivative , know contraindication implantation TYRX envelope . Current therapy chronic oral immunosuppressive agent â‰¥ 20mg/day Prednisone equivalent . Hemodialysis peritoneal dialysis . Prior Cardiac transplantation exist Ventricular Assist Device ( VAD ) . Require longterm vascular access reason . Prior history CIED infection , prosthetic device infection , endovascular infection , include endocarditis , past 12 month . Physical , clinical , laboratory sign symptom consistent active infection ( include limit pneumonia , urinary tract , cellulitis , bacteremia ) Systemic lupus erythematous , minocycline report aggravate condition Female patient pregnant , childbearing potential reliable form birth control . Women childbearing potential require negative pregnancy test within 7 day prior device procedure Participation another study may confound result study . Coenrollment concurrent trial allow documented preapproval obtain Medtronic study manager .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>